Navigation Links
Halozyme Reports Second Quarter 2012 Financial Results
Date:8/6/2012

in patients with follicular lymphoma. Roche also confirmed that data from this trial will be presented by the end of the year.
  • Presented data from two treatment studies at the American Diabetes Association's (ADA's) annual meeting that demonstrated Halozyme's ultrafast insulin formulations accelerated the absorption and action of mealtime insulins and may help reduce glucose swings. Both studies met their primary endpoint of A1C non-inferiority, significantly improved post-prandial glucose control and, in Type 1 patients, significantly reduced hypoglycemia compared to lispro alone.
  • Reported results from studies in insulin pumps at ADA that showed preadministration of Halozyme's rHuPH20 provided a more physiologic profile than current rapid insulin analogs. This also led to more consistent insulin exposure and absorption over the infusion set life. These data show that rHuPH20 preadministration may help people living with Type 1 diabetes achieve better glucose control after meals.
  • Presented data at the American Society of Clinical Oncology annual meeting that evaluated the safety and tolerability of PEGPH20 treatment, a pegylated form of rHuPH20, in patients with solid tumor malignancies, including pancreatic cancer. Data showed that PEGPH20 was generally well tolerated at the recommended Phase 2 dose, enhanced tumor perfusion and reduced tumor metabolic activity. These studies support the ongoing run-in phase of a larger study with chemotherapy in patients with pancreatic cancer.
  •  

    Second Quarter 2012 and Year-To-Date Financial Results
    The net loss for the second quarter of 2012 was $(14.0) million, or $(0.13) per share, compared with a net income for the second quarter of 2011 of $3.1 million, or $0.03 per share. The net loss for the six months ended June 30, 2012 was $(29.1) million, or $(0.27) per share, compared to a net loss of $(6.5) million, or $(0.06) per share, for the comparable period in 2011.


    '/>"/>
    SOURCE Halozyme Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
    2. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
    3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
    4. Halozyme Reports First Quarter 2012 Financial Results
    5. Halozyme to Host First Quarter 2012 Financial Results Conference Call
    6. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
    7. Press Ganey Releases Enhanced Improvement Portal with Customized Performance Reports
    8. Isis Reports Financial Results And Highlights For Second Quarter 2012
    9. Champions Oncology Reports Resignation Of Director
    10. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
    11. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... 22, 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced that its Board of Directors (the ... proposal from Endo International plc ("Endo") and, after ... has unanimously determined it is not a superior ... agreement with QLT Inc. ("QLT") and has unanimously ...
    (Date:9/19/2014)... , Sept. 19, 2014 Medical ... forging relationships with key opinion leaders (KOLs) who ... competition. Despite the critical nature of the MSL ... challenges, including altering the landscape for creating and ... According to research, the oversight responsibility for the ...
    (Date:9/19/2014)... , Sept. 19, 2014 "Copay ... inflate sales of brand drugs among patients with ... according to a new report  from the ... of the Inspector General (OIG). Federal anti-kickback laws prohibit ... that are subsidized by the federal government. ...
    Breaking Medicine Technology:Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6Role of Medical Science Liaisons Shifting in Healthcare Industry 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2
    ... Philips Respironics applauds the efforts of the Centers ... about an important public health issue -- chronic sleep ... to monitor state-by-state differences in sleeplessness is a milestone ... , As a long-time educator, industry leader and ...
    ... 6 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) will hold ... EST to discuss the third quarter 2009 financial results and business ... Officer of the Company, will host the call. Keryx will ... to be issued prior to the call. , In order to ...
    Cached Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2
    (Date:9/22/2014)... 2014 The report segments the ... user, and geography. The equipment segment accounted for ... market, by product. However, the accessories segment is ... the forecast period, owing to the rising demand ... and ultrasound segments are the fastest-growing segments in ...
    (Date:9/22/2014)... participate in athletics will be asked to sign a ... ensure parents are confident about handling the injury, according ... Hospital National Poll on Children,s Health. , In the ... and high school children surveyed reported participation in some ... read a brochure or online information, 17% have ...
    (Date:9/22/2014)... and leadership of Senators Sherrod Brown (D-Ohio) and ... primary care services were lauded yesterday by the ... organizations, representing internal medicine and related subspecialties. ... for introducing the Ensuring Access to Primary Care ... will extend current-law payment rates under Medicaid for ...
    (Date:9/22/2014)... 2014) The success of a colonoscopy is closely ... often resulting in missed precancerous lesions, according to new ... on Colorectal Cancer. Additionally, poor bowel cleansing can result ... to 20 to 25 percent of all colonoscopies are ... "When prescribing bowel preparation for their patients, health-care professionals ...
    (Date:9/22/2014)... laser weapons, the Office of Naval Research (ONR) this ... Day Marine exposition that will prepare Marines as they ... ONR program officers will be in Booth No. 2305 ... Base Quantico, to discuss how their research contributes to ... austere and lethal." , ONR,s Expeditionary Maneuver Warfare and ...
    Breaking Medicine News(10 mins):Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5Health News:Some concussion education more useful than others, parents say 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2Health News:Good bowel cleansing is key for high-quality colonoscopy 2Health News:Good bowel cleansing is key for high-quality colonoscopy 3Health News:Modern Day Marine: ONR features technology for marines of the future 2
    ... CREEK, Calif., March 7 Longs Drug,Stores Corporation ... J. Vasos has been,named executive vice president and ... who has left the Company. Vasos will,be responsible ... Vasos joined Longs in 2001 as senior ...
    ... available in Spanish . , Researchers from the ... the University of Granada have carried out a ... come to is that an efficient response in primary care ... caused by three of the most frequent pathologies in older ...
    ... health care to be released at forum, LOS ... MAYA:, What: MAYA along with leading business and ... Better Through Communication" to,seek new ways to promote better ... and the Latino Issues Forum will release the,findings of ...
    ... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... hospitalist medicine services,announced today that it will report results ... 20, 2008, before the market opens., A conference ... a.m. ET,(6:00 a.m. PT) on March 20, 2008 and ...
    ... Western Reserve University School of Medicine researchers published a ... Journal of Human Genetics identifying the hereditary components of ... in a Genome-wide Scan: Results from the Colon Neoplasia ... families with CRC and colon polyps in the country. ...
    ... physical, mental scores, study finds , , FRIDAY, March 7 ... families boosts children,s physical and mental development, a U.S. ... California, Berkeley found that children in low-income families in ... a government-run conditional cash transfer program were taller, less ...
    Cached Medicine News:Health News:Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 2Health News:An efficient response in primary care would reduce the use of hospitals by elderly people 2Health News:Nationwide Telephone News Briefing for U.S. Health Disparities Forum 2Health News:IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results 2Health News:Case Western Reserve University researchers identify colorectal cancer gene 2Health News:Government Assistance Linked to Better Child Development 2
    ... dedicated to the principles of excellence and ... committed to aiding the clinician in early ... design of profiles and panels that provide ... tests. These tests assist to resolve the ...
    ChildLab is a service of Children's Hospital, Columbus Ohio...
    Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
    Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
    Medicine Products: